• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[双嘧达莫心肌灌注显像对冠心病的诊断与分型及其预后意义]

[Detection and classification of coronary artery disease by dipyridamole perfusion scintigraphy: its prognostic significance].

作者信息

Hamashige N, Doi Y, Yonezawa Y, Kuzume O, Odawara H, Chikamori T, Ozawa T

机构信息

Department of Medicine and Geriatrics, Kochi Medical School, Nankoku.

出版信息

J Cardiol. 1989 Sep;19(3):667-78.

PMID:2641761
Abstract

To detect coronary artery disease (CAD) noninvasively and to predict the occurrence of future cardiac events, 671 patients were evaluated using dipyridamole perfusion scintigraphy. 1. Although chest pain and ST depression were induced by the administration of dipyridamole in 34% and 22% of the patients, respectively, and additional intravenous aminophylline was needed in 19% of the patients, dipyridamole perfusion scintigraphy could be completed in nearly all patients. In contrast, treadmill exercise test was not accomplished in 24% of the patients. 2. The patients were classified in three groups by scintigraphic perfusion defects; i.e., group I (322 patients) with fixed defects, group II (107 patients) with reversible defects, and group III (242 patients) without perfusion defects. The patients in Group I were subclassified three groups according to three high risk parameters (extensive fixed defect, partial redistribution and diffuse slow washout)--group Ia (69 patients) with two or more high risk parameters, group Ib (144 patients) with one high risk parameter and group Ic (109 patients) without high risk parameters. 3. Coronary angiography performed in 377 patients revealed significant CAD (luminal narrowing greater than or equal to 50%) in 96%, 89%, 56%, 90% and 8% of the patients in groups Ia, Ib, Ic, II and III, respectively. Multi-vessel CAD was present in 87%, 32%, 11%, 51% and 2% of the patients in each group, respectively.

摘要

为了无创检测冠状动脉疾病(CAD)并预测未来心脏事件的发生,我们使用双嘧达莫灌注闪烁扫描对671例患者进行了评估。1. 尽管分别有34%和22%的患者在给予双嘧达莫后出现胸痛和ST段压低,且19%的患者需要额外静脉注射氨茶碱,但几乎所有患者都能完成双嘧达莫灌注闪烁扫描。相比之下,24%的患者未能完成平板运动试验。2. 根据闪烁扫描灌注缺损情况将患者分为三组;即,I组(322例患者)为固定缺损,II组(107例患者)为可逆缺损,III组(242例患者)无灌注缺损。I组患者根据三个高危参数(广泛固定缺损、部分再分布和弥漫性缓慢洗脱)进一步分为三组——Ia组(69例患者)有两个或更多高危参数,Ib组(144例患者)有一个高危参数,Ic组(109例患者)无高危参数。3. 对377例患者进行的冠状动脉造影显示,Ia、Ib、Ic、II和III组患者中分别有96%、89%、56%、90%和8%存在显著CAD(管腔狭窄大于或等于50%)。每组患者中多支血管CAD的发生率分别为87%、32%、11%、51%和2%。

相似文献

1
[Detection and classification of coronary artery disease by dipyridamole perfusion scintigraphy: its prognostic significance].[双嘧达莫心肌灌注显像对冠心病的诊断与分型及其预后意义]
J Cardiol. 1989 Sep;19(3):667-78.
2
[Diagnosis and prognosis of elderly patients with coronary artery disease: assessment with dipyridamole thallium imaging].[老年冠心病患者的诊断与预后:双嘧达莫铊显像评估]
J Cardiol. 1995 Oct;26(4):219-26.
3
[Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value].[双嘧达莫负荷铊心肌显像在急性心肌梗死溶栓治疗中的诊断和预后价值]
G Ital Cardiol. 1994 Jan;24(1):11-20.
4
[Coronary artery disease detected noninvasively by dipyridamole-loading 201T1 myocardial scintigraphy in elderly patients].
J Cardiogr. 1986 Mar;16(1):43-51.
5
[Assessment of prognosis of old myocardial infarction].[老年心肌梗死的预后评估]
J Cardiol. 1992;22(1):51-60.
6
Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation.双嘧达莫-铊201筛查对降低接受肾移植或肾胰联合移植的糖尿病患者围手术期心脏并发症的预后价值。
Clin Transplant. 1998 Apr;12(2):130-5.
7
[Indication for coronary revascularization for angina pectoris: correlation with prognosis of medically-treated patients].[心绞痛冠状动脉血运重建的指征:与药物治疗患者预后的相关性]
J Cardiol. 1989 Dec;19(4):1061-71.
8
[Clinical significance of negative dipyridamole perfusion scintigram].[双嘧达莫灌注闪烁造影阴性的临床意义]
Kaku Igaku. 1989 Jun;26(6):753-62.
9
Isoproterenol stress thallium scintigraphy for detecting coronary artery disease.用于检测冠状动脉疾病的异丙肾上腺素负荷铊闪烁扫描术。
J Cardiol. 1989 Sep;19(3):657-65.
10
[Noninvasive identification of left main and triple vessel coronary artery disease using dipyridamole thallium scintigraphy].[使用双嘧达莫铊闪烁扫描术对左主干和三支血管冠状动脉疾病进行无创识别]
J Cardiol. 1993;23(2):141-7.